Wojtek Wojakowski
Overview
Explore the profile of Wojtek Wojakowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
2919
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dafaalla M, Costa F, Jia H, Wijeysundera H, Rashid M, Graham M, et al.
Eur Heart J Open
. 2025 Mar;
5(2):oeaf012.
PMID: 40070878
Aims: Treatment of patients with cancer presenting with ST-elevation myocardial infarction (STEMI) is complex given the increased risk of both thrombotic and major bleeding complications. Methods And Results: A nationally...
2.
Kedhi E, Hermanides R, Dambrink J, Singh S, Ten Berg J, van Ginkel D, et al.
Lancet
. 2024 Dec;
404(10471):2593-2602.
PMID: 39644913
Background: Patients with severe aortic stenosis present frequently (∼50%) with concomitant obstructive coronary artery disease. Current guidelines recommend combined surgical aortic valve replacement (SAVR) and coronary artery bypass grafting (CABG)...
3.
Appleby C, Bleiziffer S, Bramlage P, Delgado V, Eltchaninoff H, Gebhard C, et al.
J Thorac Dis
. 2024 Oct;
16(9):6308-6319.
PMID: 39444914
This state-of-the-art review aimed to synthesize evidence from various sex-stratified studies on aortic stenosis (AS), focusing on the difference in clinical presentation, anatomical characteristics, pathophysiology, and management of AS. In...
4.
Leikas A, Hartikainen J, Kastrup J, Mathur A, Gyongyosi M, Fernandez-Aviles F, et al.
Open Heart
. 2024 Oct;
11(2).
PMID: 39424303
Background: Despite tremendous therapeutic advancements, a significant proportion of coronary artery disease patients suffer from refractory angina pectoris, that is, quality-of-life-compromising angina that is non-manageable with established pharmacological and interventional...
5.
Peszek-Przybyla E, Jedrzejek M, Smolka G, Quinn M, Pysz P, Wojakowski W
Struct Heart
. 2024 Sep;
8(5):100329.
PMID: 39290678
Background: Tricuspid regurgitation (TR) is a common valvular disorder with limited treatment options. It occurs when tricuspid leaflet closure is prevented by dilation of the right heart or in patients...
6.
Banovic M, Putnik S, da Costa B, Penicka M, Deja M, Kotrc M, et al.
Eur Heart J
. 2024 Sep;
45(42):4526-4535.
PMID: 39217448
Background And Aims: The question of when and how to treat truly asymptomatic patients with severe aortic stenosis (AS) and normal left ventricular (LV) systolic function is still subject to...
7.
Bleiziffer S, Appleby C, Delgado V, Eltchaninoff H, Gebhard C, Hengstenberg C, et al.
Int J Cardiol
. 2024 Mar;
406:131996.
PMID: 38555056
Objective: Management of patients with severe aortic stenosis (AS) may differ according to the patient sex. This study aimed to describe patterns of aortic valve replacement (AVR) for severe AS...
8.
Pasceri V, Pelliccia F, Mehran R, Dangas G, Porto I, Radico F, et al.
J Am Heart Assoc
. 2024 Mar;
13(7):e032955.
PMID: 38533944
Background: Dialysis is a rare but serious complication after transcatheter aortic valve replacement. We analyzed the large multicenter TRITAVI (transfusion requirements in transcatheter aortic valve implantation) registry in order to...
9.
Herman R, Meyers H, Smith S, Bertolone D, Leone A, Bermpeis K, et al.
Eur Heart J Digit Health
. 2024 Mar;
5(2):123-133.
PMID: 38505483
Aims: A majority of acute coronary syndromes (ACS) present without typical ST elevation. One-third of non-ST-elevation myocardial infarction (NSTEMI) patients have an acutely occluded culprit coronary artery [occlusion myocardial infarction...
10.
Zimerman A, Wiviott S, Park J, Murphy S, Ran X, Bramson C, et al.
Eur J Prev Cardiol
. 2024 Mar;
31(10):1216-1223.
PMID: 38484368
Aims: Remnant cholesterol and very low-density lipoprotein cholesterol (VLDL-C) are increasingly recognized risk factors for atherosclerotic disease with few therapeutic options. Angiopoietin-like 3 (ANGPTL3), a key protein in the metabolism...